Polpharma looks to challenge Takeda's Entyvio in IBD Clinical Trials Arena - 22 Feb 2024 Polpharma looks to challenge Takeda's Entyvio in IBD ... More
FDA approves Tysabri biosimilar BioProcess Insider - 29 Feb 2024 FDA approves Tysabri biosimilar ... More
Polpharma Biologics gets greenlight for first multiple sclerosis biosimilar in Europe BioPharma-Reporter.com - 26 Sep 2023 Polpharma Biologics gets greenlight for first multiple sclerosis biosimilar in Europe ... More
Forward-thinking CDMO tackles the dynamic challenge of N-nitrosamines control with high-performance analytical ... European Pharmaceutical Review - 01 Mar 2024 Forward-thinking CDMO tackles the dynamic challenge of N-nitrosamines control with high-performance analytical ... ... More
EC Approves Polpharma Biologics' MS-Treating Biosimilar Pharmaceutical Technology Magazine - 28 Sep 2023 EC Approves Polpharma Biologics' MS-Treating Biosimilar ... More
Positive trial results for Polpharma's Entyvio biosimilar for IBD The Pharma Letter - 21 Feb 2024 Positive trial results for Polpharma's Entyvio biosimilar for IBD ... More
Polpharma Bio gets first EU okay for Tysabri biosimilar pharmaphorum - 26 Sep 2023 Polpharma Bio gets first EU okay for Tysabri biosimilar ... More
EBRD supports development of Poland's pharmaceutical sector EBRD - 16 Apr 2024 EBRD supports development of Poland's pharmaceutical sector ... More
CEO of Polpharma Group Explores Company’s Impactful Activities in Kazakhstan, Shares Vision on Global Trends Astana Times - 08 Jun 2023 CEO of Polpharma Group Explores Company’s Impactful Activities in Kazakhstan, Shares Vision on Global Trends ... More
Polpharma Biologics gets FDA green light for multiple sclerosis treatment BioPharma-Reporter.com - 25 Aug 2023 Polpharma Biologics gets FDA green light for multiple sclerosis treatment ... More
EXCLUSIVE Polish drug maker Polpharma working on bid for Advent's Zentiva - sources Reuters.com - 20 Jan 2022 EXCLUSIVE Polish drug maker Polpharma working on bid for Advent's Zentiva - sources ... More
Sandoz granted positive CHMP opinion for multiple sclerosis biosimilar PMLiVE - 24 Jul 2023 Sandoz granted positive CHMP opinion for multiple sclerosis biosimilar ... More
Sandoz's Tyruko biosimilar granted FDA approval to treat relapsing MS - PharmaTimes PharmaTimes - 25 Aug 2023 Sandoz's Tyruko biosimilar granted FDA approval to treat relapsing MS - PharmaTimes ... More
Polpharma Biologics Executives Discuss Ranibizumab Biosimilar and Other Product Candidates The Center for Biosimilars - 13 Oct 2021 Polpharma Biologics Executives Discuss Ranibizumab Biosimilar and Other Product Candidates ... More
EC approves Tyruko, first MS biosimilar in Europe The Pharma Letter - 26 Sep 2023 EC approves Tyruko, first MS biosimilar in Europe ... More
Polpharma Biologics: The Polish Biosimilar Powerhouse The Center for Biosimilars - 11 Aug 2020 Polpharma Biologics: The Polish Biosimilar Powerhouse ... More